Livelivant IV infusion 350mg (Amivantamab), from Janssen Pharmaceutical (YJ code: 4291473A1024, standard: 350mg 7mL bottle), is a bispecific antibody used for treating non-small cell lung cancer with EGFR exon 20 insertion mutations. It targets both epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition (MET) receptors.
Livelivant IV infusion 350mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →